Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial.
about
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapyAnti-tumor Activity of Toll-Like Receptor 7 Agonists.Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma.Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments.
P2860
Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial.
@ast
Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial.
@en
type
label
Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial.
@ast
Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial.
@en
prefLabel
Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial.
@ast
Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial.
@en
P2093
P2860
P921
P356
P1433
P1476
Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial.
@en
P2093
Adama Sacko
Annick Tibi
Antoine F Carpentier
Athina Marantidou
Catherine Belin
Claire Banissi
Dimitri Psimaras
Emilie Le Rhun
Eric Vicaut
Jean-Sebastien Guillamo
P2860
P304
P356
10.1111/CAS.12724
P577
2015-06-19T00:00:00Z